• Movie

    Click here for the video of Kyoto.

  • Important Dates:

    August 31, 2017
    Deadline Advanced Registration

    June 30, 2017
    Extended to July 31, 2017
    Deadline Early Bird Registration

    May 21, 2017
    Deadline Late-Breaking Abstract Submission

    April 30, 2017
    Notification Abstract/Poster Presentations

    February 28, 2017
    March 14, 2017

    Deadline Abstract Submission

    December 1, 2016
    Registration Open
    Hotel Reservation Open

    October 18, 2016
    Abstract Submission Open

Post-Congress Meeting

Post Congress Symposium

Post Congress Symposium “Guidelines and Consensus Documents for TDM”

Date: Thursday, September 28, 2017
Venue: Room D, Kyoto International Conference Center, Kyoto, Japan
Lecture Time: 30 minutes (including Q&A)

8:40 - 8:45 Opening Remark
Yusuke Tanigawara (Chair of the 15th IATDMCT Congress, Keio University, Japan)
8:45 - 9:15
PC-1
Therapeutic Drug Monitoring of Everolimus
Maria Shipkova (Immunosuppressive Drugs Scientific Committee of the IATDMCT,
Klinikum Stuttgart, Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin,, Germany)
9:15 - 9:45
PC-2
Guidelines on Therapeutic Drug Monitoring of Immunosuppressive Drugs
Used in Organ Transplantation
Satohiro Masuda (Japanese Society of Therapeutic Drug Monitoring (JSTDM),
Kyushu University Hospital, Japan)
9:45 - 10:15
PC-3
Analytical methods of Measurement for Immunosuppressive Drug Concentrations
TBA (Immunosuppressive Drugs Scientific Committee of the IATDMCT)
10:15 - 10:45 Break
10:45 - 11:15
PC-4
Dried blood spot (DBS) sampling and analysis guideline
Christoph Stove (Alternative Sampling Strategies Committee of the IATDMCT
Laboratory of Toxicology, Ghent University, Belgium)
11:15 - 11:45
PC-5
Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs
Tsuyoshi Shiga (Japanese Society of Therapeutic Drug Monitoring (JSTDM),
Tokyo Women's Medical University, Japan)
11:45 - 13:00 Lunch
13:00 - 13:30
PC-6
Draft Guideline on TDM of 5-FU
Edward Chu (TDM in Oncology Scientific Committee of the IATDMCT,
University of Pittsburgh Cancer Institute, USA)
13:30 - 14:00
PC-7
Busulfan TDM: Current consensus and discrepancy
Erik van Maarseveen (TDM in Oncology Scientific Committee of the IATDMCT,
University Medical Center Utrecht, The Netherlands)
14:00 - 14:30
PC-8
Concept paper on imatinib TDM
William Clarke (TDM in Oncology Scientific Committee of the IATDMCT,
Johns Hopkins School of Medicine, USA)
14:30 - 15:00 Break
15:00 - 15:30
PC-9
Draft guidance for linezolid TDM
Gauri Rao (Anti-Infective Drugs Committee of the IATDMCT, University at North Carolina, USA)
15:30 - 16:00
PC-10
Guidelines for Therapeutic Drug Monitoring of Antiepileptic Drugs
Toshiaki Sendo (Japanese Society of Therapeutic Drug Monitoring (JSTDM),
Okayama University Hospital, Japan)
16:00 - 16:15 Closing Remark
Satohiro Masuda (Secretary of the 15th IATDMCT Congress,
Kyushu University Hospital, Japan)

Registration

Post-Congress Meeting Registration Fee (Currency: Japanese Yen (JPY))

September 28, Thursday, 2017 Program details

Category IATDMCT/Affiliate
member
Young Scientists/Junior member/Student Non-member
Early Bird Registration
(Until July 31, 2017)
JPY6,000 JPY4,000 JPY15,000
Advanced Registration
(Until August 31, 2017)
JPY8,000 JPY5,000 JPY20,000
On-site Registration JPY10,000 JPY6,000 JPY30,000

Post-Congress Meeting Registration Fee includes:
Lunch Thursday, morning and afternoon refreshment breaks, access to all sessions during the Post-Congress Meeting.